Biography
Pierre Giguère holds a bachelor’s degree in pharmacy and a master’s degree in hospital pharmacy. In 2010, he completed a master’s with research paper in epidemiology and community medicine at the University of Ottawa. In addition, he holds a certificate in pharmacy from the The American Academy of HIV Medicine. Mr. Giguère has spent his career as a hospital pharmacist, working primarily in the area of viral diseases in the ambulatory setting (HIV, HCV, HBV). For over 20 years, he has dedicated his efforts as a clinical pharmacist to the Immunodeficiency Clinic and the Viral Hepatitis Program at The Ottawa Hospital. He is an executive member of the Canadian HIV and Viral Hepatitis Pharmacists Network. Mr. Giguère is committed to sharing his knowledge by collaborating in the development and updating of a web-based tool for the management of drug interactions with antiretrovirals and direct-acting agents.
Expertise
- Pharmacotherapy (with specialty in HIV, HCV and other viral hepatitis diseases)
- Epidemiology
- Drug interactionss
- Clinical research
- Ethics
Research Projects
Mr Giguère is involved in research in the area of pharmaceutical practice and HIV/HCV. As a member of The Ottawa Hospital pharmacy research committee, he supports research initiatives in the hospital pharmacist residency program.
- Ellen D, Pierre G, Jamie B. National Survey Assessing Knowledge and Management of the Drug Interaction between Dolutegravir and Metformin by Canadian HIV Practitioners. Oral presentation at: 27th Canadian Conference on HIV/AIDS Research; April, 2018; Vancouver. https://www.cahr-acrv.ca/wp-content/uploads/2018/04/CAHR2018-Abstract-Book-with-Errata.pdf
- Chowdhry U, Jacques A, Karovitch A, Giguère P, Nguyen ML. Appropriateness of Dabigatran and Rivaroxaban Prescribing for Hospital Inpatients.
Can J Hosp Pharm. 2016;69(3):194-201. doi:10.4212/cjhp.v69i3.1555 - Mistry M, Shea A, Giguère P, Nguyen ML. Evaluation of Sodium Polystyrene Sulfonate Dosing Strategies in the Inpatient Management of Hyperkalemia.Ann Pharmacother. 2016;50(6):455-462. doi:10.1177/1060028016641427
- Giguère P. Microboosting of Atazanavir 300mg with 50mg versus 100mg of ritonavir daily in HIV-infected patients. Oral presentation at: 16th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy; May, 2015; Washington D.C.
- Laurent H, Paul M, Kim C, Tara L, Pierre G. Tolerability of Darunavir/Ritonavir, Tenofovir/Emtricitabine for HIV Postexposure Prophylaxis. Oral presentation at: 23rd Annual Canadian Conference on HIV/AIDS Research; May, 2014. St-John’s. https://www.cahr-acrv.ca/conference/archives/cahr-conference-2014/
- Hull M, Giguère P, Klein M, et al. Le Domaine des co-infections et des maladies concomitantes du Réseau Canadien pour les Essais vih des IRSC : Lignes directrices canadiennes pour la prise en charge et le traitement de la co-infection par le vih et l’hépatite C chez les adultes. Canadian Journal of Infectious Diseases and Medical Microbiology. 2014;25(1):39-62. doi:10.1155/2014/921314
- Jacques AC, Lougheed C, Macdonald E, Karovitch A, Giguère P. Effectiveness of Unfractionated Heparin in Normal Saline versus Dextrose for Achieving and Maintaining Therapeutic Anti-Factor Xa Levels in Patients with Non-ST-Elevation Acute Coronary Syndrome.Can J Hosp Pharm. 2013;66(6):347-354. doi:10.4212/cjhp.v66i6.1299
- Toy J, Giguère P, Kravcik S, la Porte CJ. Drug interactions between voriconazole, darunavir/ritonavir and etravirine in an HIV-infected patient with Aspergillus pneumonia.AIDS. 2011;25(4):541-542. doi:10.1097/QAD.0b013e32834403cd
- Jacques AC, Giguère P, Zhang G, Touchie C, la Porte CJ. Atazanavir-associated choledocholithiasis leading to acute hepatitis in an HIV-infected adult.Ann Pharmacother. 2010;44(1):202-206. doi:10.1345/aph.1M489
- Giguère P. Cost effectiveness analysis of abacavir/lamivudine versus tenofovir/emtricitabine combination therapy as part of highly active antiretroviral therapy in treatment naive HIV-infected patients. Master Thesis. University of Ottawa; 2010. https://ruor.uottawa.ca/bitstream/10393/28523/1/MR65545.PDF
Awards and Nominations
- Nomination, “Commitment to Quality" category (2021), The Ottawa Hospital (TOH) Excellence Awards
- The Innovative Information Technology Award (2016), Canadian Society of Hospital Pharmacists, Ontario branch
- Specialties in Pharmacy Practice Award (2016), Canadian Society of Hospital Pharmacists, 2016
- E. Emy Eck Award (2016), Hospital Project, Canadian Society of Hospital Pharmacists, Ontario branch
- Teaching, Learning and Educational Award (2013), Canadian Society of Hospital Pharmacists